These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2386012)

  • 21. The inter-relationship of factor VII and its activity state with plasma lipids in healthy male adults.
    Wright D; Poller L; Thomson JM; Gowland E; Burrows GE
    Br J Haematol; 1993 Oct; 85(2):348-51. PubMed ID: 8280607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipase C mediated inhibition of factor VII requires triglyceride-rich lipoproteins.
    Hubbard AR; Parr LJ
    Thromb Res; 1991 May; 62(4):335-44. PubMed ID: 1866715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
    Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
    Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital deficiency of factor VII in subarachnoid hemorrhage.
    Papa ML; Schisano G; Franco A; Nina P
    Stroke; 1994 Feb; 25(2):508-10. PubMed ID: 8303765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of Simvastatin upon serum pseudocholinesterase and plasmatic factor VII.
    Zdrenghea D; Bodizs G; Predescu D; Oprea M; Zdrenghea M
    Rom J Intern Med; 2002; 40(1-4):3-9. PubMed ID: 15526536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
    Mamont B; Sawicka B
    Kardiol Pol; 1992 Nov; 37(11):283-6. PubMed ID: 1287288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation factor VII, serum-triglycerides and the R/Q353 polymorphism: differences between older men and women.
    Mennen LI; de Maat MP; Schouten EG; Kluft C; de Jong PT; Hofman A; Grobbee DE
    Thromb Haemost; 1997 Sep; 78(3):984-6. PubMed ID: 9308739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is factor VII activation in pregnant women relevant to fetal growth retardation?
    Scarabin PY; Bonithon-Kopp C; Bara L; Samama M; Blot P
    Thromb Res; 1987 Mar; 45(6):845-50. PubMed ID: 3495902
    [No Abstract]   [Full Text] [Related]  

  • 30. Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
    Mukherjee M; Dawson G; Sembhi K; Kakkar VV
    Thromb Haemost; 1996 Oct; 76(4):500-1. PubMed ID: 8902984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do oxidized fatty acids activate coagulation factor VII during post-prandial lipemia in women?
    Wilson R; Lyall K; Millar EM; Smyth L; Pearson C; Riemersma RA
    Thromb Haemost; 2003 Apr; 89(4):654-9. PubMed ID: 12669119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.
    Sandset PM; Hellgren M; Uvebrandt M; Bergström H
    Thromb Res; 1989 Sep; 55(5):665-70. PubMed ID: 2814949
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease.
    Hoffman CJ; Miller RH; Lawson WE; Hultin MB
    J Am Coll Cardiol; 1989 Oct; 14(4):941-6. PubMed ID: 2794283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
    Cushman M; Yanez D; Psaty BM; Fried LP; Heiss G; Lee M; Polak JF; Savage PJ; Tracy RP
    Am J Epidemiol; 1996 Apr; 143(7):665-76. PubMed ID: 8651228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Chapman J; Truffert J; Dairou F; De Gennes JL; Caen JP
    Haemostasis; 1989; 19(3):125-30. PubMed ID: 2744628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor VII in subjects at risk for thromboembolism: activation or increased synthesis?
    Orlando M; Leri O; Macioce G; Mattia G; Ferri GM
    Haemostasis; 1987; 17(6):340-3. PubMed ID: 3428720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VII deficiency and pregnancy.
    Fadel HE; Krauss JS
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):453-4. PubMed ID: 2915871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on coagulation and fibrinolysis in blood from puerperal women with and without oestrogen treatment.
    Gjonnaess H; Fagerhol MK; Stormorken H
    Br J Obstet Gynaecol; 1975 Feb; 82(2):151-7. PubMed ID: 123756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.
    Mann KG
    Arteriosclerosis; 1989; 9(6):783-4. PubMed ID: 2590061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.